Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies

Details for Australian Patent Application No. 2003256823 (hide)

International Classifications

Event Publications

6 November 2003 Complete Application Filed

Priority application(s): 60/398,475 25.07.02 US

25 March 2004 Application Open to Public Inspection

Published as AU-B-2003256823

7 June 2007 Change of Name(s) of Applicant(s), Section 104

Medimmune, Inc.; Vironovative B.V. The name of the applicant has been changed to MedImmune, Inc.; ViroNovative B.V.

2 October 2008 Alteration of Name

The name of the applicant has been altered to ViroNovative B.V.; MedImmune, LLC

6 November 2008 Application Accepted

Published as AU-B-2003256823

5 March 2009 Standard Patent Sealed

18 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.